

Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement. The investors included Bpifrance Participations.
Source: Press Release
Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement.
Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement. The investors included Bpifrance Participations.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination